Exor NV (0RKY)
London Stock Exchange · UK · prices in EUR · close of 28 Oct 2026
Key indicators
| Last close | EUR 70.28 |
|---|---|
| 52-week range | 59.85 – 80.00 |
| Return, 1 month / 3 months | −1.2% / +1.3% |
| Return, 1 year / 3 years | −8.0% / −13.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 51 |
| Volatility (1 year) | 21.5% |
| Worst drawdown (1 year) | -17.9% |
| Average daily value traded | 3.70M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Exor is an investment holding company controlled by the Agnelli family and based in the Netherlands. It owns and manages a portfolio of businesses across several industries, including cars and commercial vehicles through its interests in Ferrari, Stellantis and CNH Industrial, and reinsurance through PartnerRe. It also holds stakes in media and sports businesses. Exor's customers are the end users of the companies it controls, and its own role is to allocate capital and oversee those operating businesses.
On this site Exor NV appears as a stock on the London Stock Exchange (UK), code 0RKY, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Exor NV (0RKY) trades on the London Stock Exchange in UK. It last closed at EUR 70.28 on 28 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,002 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.0% and over the last three months it rose 1.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.3% | ||
| From 52-week high | -9.4% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.3% | ||
| 6-month return | 5.1% | ||
| 12-month return, skipping the last month | -6.9% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.9% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.70M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | −1.2% |
| 3 months | +1.3% |
| 6 months | +5.1% |
| 1 year | −8.0% |
| 3 years | −13.9% |
| 5 years | −12.0% |
Signals
| 50-day / 200-day average | 70.82 / 69.34 |
|---|---|
| Golden / death cross (60 days) | Golden, 31 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.52 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jun 2022 | EUR 0.4300 |
| 21 Jun 2021 | EUR 0.4300 |
| 22 Jun 2020 | EUR 0.4300 |
| 24 Jun 2019 | EUR 0.4300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.